Pharmacokinetic Variability of Newer Antiepileptic Drugs: When is Monitoring Needed?

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.45, Iss.11, 2006-01, pp. : 1061-1075

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Restoring Confidence in Vaccines by Explaining Vaccine Safety Monitoring: Is a Targeted Approach Needed?

By Casiday Rachel E.

Drug Safety, Vol. 29, Iss. 12, 2006-01 ,pp. : 1105-1109

Adis International

Access to resources Recommend Favorite

Teratogenic Potential of the Newer Antiepileptic Drugs: What is Known and How Should This Influence Prescribing?

By Palmieri C. Canger R.

CNS Drugs, Vol. 16, Iss. 11, 2002-01 ,pp. : 755-764

Adis International

Access to resources Recommend Favorite

Alternative primary endpoints for cancer trials needed?

Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Suicidality and Antiepileptic Drugs: Is there a Link?

By Kalinin Vladimir V.

Drug Safety, Vol. 30, Iss. 2, 2007-01 ,pp. : 123-142

Adis International

Access to resources Recommend Favorite

Therapeutic Monitoring of Antiepileptic Drugs during Pregnancy and in the Postpartum Period: Is It Useful?

By Adab Naghme

CNS Drugs, Vol. 20, Iss. 10, 2006-01 ,pp. : 791-800

Adis International

Access to resources Recommend Favorite